drugset / Trial / NCT05083910

Randomization of Oxytocin, Oxytocin+Intrauterine Misoprostol and Carbetocin During C-section

NCT05083910

Completed 156 enrolled Bezmialem Vakif University
RandomizedParallel-groupSingle-blindPrevention

Summary

Postpartum haemorrhage (PPH) remains an important cause of maternal morbidity and mortality and it accounts for approximately 25% of all deaths worldwide. Drugs such as oxytocin, carbetocin, misoprostol, prostaglandin F2a and methylergonovine have been tested for bleeding control during and after cesarean section. Oxytocin is the most widely used agent for the prevention of postpartum hemorrhage.The primary aim of this study is to reduce the mean blood loss during cesarean section.In this study, the investigators planned to compare peroperative and postoperative blood loss levels by giving oxytocin alone to the 1st group, oxytocin and intrauterine misoprostol to the 2nd group, and carbetocin to the 3rd group of patients who were randomly divided into 3 groups.In this study, we aimed to compare the efficacy of oxytocin, misoprostol and carbetocin in preventing uterine blood loss during cesarean section.

Timeline

Start
2021-07-01
Primary completion
2022-01-22
Completion
2022-01-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Carbetocin Peptide 100 mg Intravenous
Subject Misoprostol Other / unclassified 400 mg Other
Subject Oxytocin Peptide 20 iu Intravenous

Indications

No indication recorded.